Patents by Inventor Timothy J. Fultz

Timothy J. Fultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT
    Publication number: 20120045508
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: April 9, 2010
    Publication date: February 23, 2012
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
    Publication number: 20120046365
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 23, 2012
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Methods and compositions for the treatment of CNS-related conditions
    Patent number: 8058291
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: November 15, 2011
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz
  • COMPOSITIONS AND KITS FOR TREATING INFLUENZA
    Publication number: 20110230432
    Abstract: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
    Type: Application
    Filed: May 26, 2011
    Publication date: September 22, 2011
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Jack Nguyen, Gregory T. Went, Paul Spence, Timothy J. Fultz, David Chernoff
  • Compositions and kits for treating influenza
    Patent number: 7981930
    Abstract: Kits comprising an M2 inhibitor selected from amantadine and rimantadine; ribavirin, and a neuraminidase inhibitor (NAi) in an amount that is antivirally effective in the combination, an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin and a neuraminidase inhibitor are provided for the treatment of influenza. Some embodiments of the kits comprise an oral dosage form containing 75-250 mg of the M2 inhibitor, an oral dosage form comprising 100-400 mg of ribavirin, and a neuraminidase inhibitor.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: July 19, 2011
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Jack Nguyen, Gregory T. Went, Paul Spence, Timothy J. Fultz, David Chernoff, Terry L. Burkoth, Rowan Chapman, Mickey S. Urdea
  • Methods and Compositions for the Treatment of CNS-Related Conditions
    Publication number: 20110064804
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
    Type: Application
    Filed: April 9, 2010
    Publication date: March 17, 2011
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz
  • Compositions and kits for treating influenza
    Patent number: 7858660
    Abstract: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: December 28, 2010
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Jack Nguyen, Gregory T. Went, Paul Spence, Timothy J. Fultz, David Chernoff, Terry L. Burkoth, Rowan Chapman, Mickey S. Urdea
  • Methods and Compositions for the Treatment of CNS-Related Conditions
    Publication number: 20100311697
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
    Type: Application
    Filed: April 2, 2010
    Publication date: December 9, 2010
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz
  • Methods and Compositions for the Treatment of Psychiatric Conditions
    Publication number: 20100292216
    Abstract: This invention relates to methods and compositions for treating psychiatric conditions, such as depression.
    Type: Application
    Filed: November 16, 2009
    Publication date: November 18, 2010
    Applicant: ADAMAS PHARMACEUTICALS, INC.
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT
    Publication number: 20100266684
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 21, 2010
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT
    Publication number: 20100260838
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 14, 2010
    Applicant: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
    Publication number: 20100047342
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Application
    Filed: July 30, 2009
    Publication date: February 25, 2010
    Applicant: ADAMAS PHARMACEUTICALS, INC.
    Inventors: Gregory T. Went, Timothy J. Fultz, Seth Porter, Laurence R. Meyerson, Timothy S. Burkoth
  • Methods and Compositions for Treating Migraine Pain
    Publication number: 20100029665
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of headaches, vascular headaches, migraine headaches, cluster headaches, and migraine. One of the headaches, vascular headaches, migraine headaches, cluster headaches, and migraine treated by the methods and compositions of the invention is migraine.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 4, 2010
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz, Timothy S. Burkoth
  • Methods and Compositions for the Treatment of CNS-Related Conditions
    Publication number: 20100022659
    Abstract: The invention provides methods and compositions for the treatment of dementia-related conditions, such as Parkinson's disease and Alzheimer's disease.
    Type: Application
    Filed: June 24, 2009
    Publication date: January 28, 2010
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • Emergency Preparations for an Epidemic
    Publication number: 20090326978
    Abstract: Stockpiles and methods of stockpiling a combination antiviral therapy for responding to an epidemic viral outbreak are described. Methods and systems of inventory control for co-deployment of drugs used in combination during a pandemic are described.
    Type: Application
    Filed: June 30, 2009
    Publication date: December 31, 2009
    Inventors: Timothy J. Fultz, Gregory T. Went, Jack Nguyen, Paul Spence, David Chernoff, Terry L. Burkoth, Rowan Chapman, Mickey S. Urdea
  • Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
    Publication number: 20090306051
    Abstract: The present invention relates to methods and compositions for treating CNS-related disorders.
    Type: Application
    Filed: December 11, 2008
    Publication date: December 10, 2009
    Inventors: Laurence R. Meyerson, Gregory T. Went, Timothy J. Fultz
  • Method and composition for administering an NMDA receptor antagonist to a subject
    Patent number: 7619007
    Abstract: The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: November 17, 2009
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson
  • Compositions and Kits for Treating Influenza
    Publication number: 20090247481
    Abstract: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
    Type: Application
    Filed: June 2, 2009
    Publication date: October 1, 2009
    Applicant: ADAMAS PHARMACEUTICALS, INC.
    Inventors: Jack Nguyen, Gregory T. Went, Paul Spence, Timothy J. Fultz, David Chernoff, Terry L. Burkoth, Rowan Chapman, Mickey S. Urdea
  • Combinations Therapy for Treatment of Demyelinating Conditions
    Publication number: 20080279819
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of demyelinating conditions. One demyelinating condition treated by the methods and compositions of the invention is multiple sclerosis. Also treated are symptoms associated with multiple sclerosis.
    Type: Application
    Filed: February 15, 2006
    Publication date: November 13, 2008
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson, David Chernoff
  • Compositions and Kits for Treating Influenza
    Publication number: 20080227743
    Abstract: Compositions, kits and methods are provided for the treatment or prophylaxis of influenza.
    Type: Application
    Filed: February 29, 2008
    Publication date: September 18, 2008
    Inventors: Jack Nguyen, Gregory T. Went, Paul Spence, Timothy J. Fultz, David Chernoff